Black Rock Inc. Lucira Health, Inc. Transaction History

Black Rock Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.11 - $0.83 $101 - $763	920 Added 1.76%	53,206 $5,000
Q3 2022 Nov 14, 2022	SELL	$1.27 - $3.39 $1,460 - $3,898	-1,150 Reduced 2.15%	52,286 $56,000
Q2 2022 Aug 12, 2022	BUY	$1.44 - $3.94 $2,833 - $7,753	1,968 Added 3.82%	53,436 $99,000
Q1 2022 May 12, 2022	BUY	$2.86 - $8.83 $23,254 - $71,796	8,131 Added 18.76%	51,468 $183,000
Q4 2021 Feb 10, 2022	SELL	$4.94 - $8.94 $53,470 - $96,766	-10,824 Reduced 19.98%	43,337 $373,000
Q3 2021 Nov 09, 2021	BUY	$6.05 - $10.81 $156,773 - $280,119	25,913 Added 91.73%	54,161 $412,000
Q2 2021 Aug 11, 2021	BUY	$4.56 - $11.45 $128,810 - $323,439	28,248 New	28,248 $187,000

Ticker LHDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,106,500
Market Cap $1.2M
Description
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a paten...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.